Living with Parkinson’s can be stressful, triggering a cascade of worries. Anxiety is common among people with Parkinson’s and can take many forms: general anxiety, panic attacks, social phobia or attacks brought on by isolated instances, to name a few.
There are approximately 3,000 movement disorder specialists in the world. While they are all neurologists, not all of them have experience treating Parkinson’s disease (PD). For every person with Parkinson’s to receive treatment from a specialist, each one of these doctors would have to treat more than 3,000 people with PD. Parkinson’s Foundation estimates that the average movement disorder specialist sees a total of 350 patients. That’s more than 8.9 million people with PD who are not being treated by a specialist.
Should we consider subcutaneous apomorphine infusions for Parkinson’s disease patients who do not want deep brain stimulation or a dopamine pump? There is a growing interest among people with Parkinson’s disease (PD) and families for a “nonsurgical” alternative to deep brain stimulation (DBS) surgery or to Duopa pump therapy. The idea of brain surgery or a feeding tube have been cited as being undesirable for large numbers of PD patients.
Parkinson’s disease (PD) has seen an elevation in recognition over the last few decades. Through the help of media, celebrities and events that promote PD awareness, Parkinson’s is far from an unknown disease. While we still have a long way to go to educate and make everyone aware of Parkinson’s and its impact, the history of this disease goes back to 1,000 B.C.
With medical marijuana legalized in 28 states and Washington, D.C., its therapeutic properties have become buzzworthy. Researchers are currently studying these properties and how they affect different diseases, like Parkinson’s disease (PD). But why?
Part of Steven Goldenthal’s job is to get people connected. He wants to know how they feel, gets to know their medical history, what medications they take and if they are happy with their Parkinson’s disease (PD) care.
You already know that exercise is essential to living a healthy lifestyle, especially for people with Parkinson’s disease (PD). Exercise helps people with PD maintain balance, mobility and helps with daily living activities, not to mention it provides neuroprotective benefits.
Safinamide (Xadago) was approved by the Food and Drug Administration (FDA) for treatment of Parkinson’s disease (PD) medication fluctuations. Safinamide is a pill that when absorbed in the bloodstream travels to the brain and affects dopaminergic and non-dopaminergic systems.
In Mood: A Mind's Guide to Parkinson’s, the newest educational book from the Parkinson’s Foundation, we explore mood changes associated with Parkinson’s disease (PD), why people with Parkinson’s might experience these changes and how to treat and cope with them.